Breaking News Instant updates and real-time market news.

VRTX

Vertex

$179.85

1.08 (0.60%)

06:36
09/03/19
09/03
06:36
09/03/19
06:36

Vertex upgraded to Conviction Buy from Buy at Goldman Sachs

Goldman Sachs analyst Salveen Richter added Vertex Pharmaceuticals to his firm's Americas Conviction List while raising his price target for the shares to $254 from $226 and keeping a Buy rating on the name. Vertex is in the midst of a multi-year period of "rapid" margin expansion and earnings outperformance driven by growth of the legacy cystic fibrosis franchise and likely launch of VX-445 triple combination, which has a March 19 FDA action date, Richter tells investors in a research note. Further, the analyst believes investor attention should now shift to the company's emerging pipeline, where he sees a "significant opportunity" in the Phase 2-ready alpha-1 antitrypsin deficiency disorder program.

  • 09

    Sep

  • 19

    Mar

VRTX Vertex
$179.85

1.08 (0.60%)

08/20/19
PIPR
08/20/19
NO CHANGE
PIPR
Piper Jaffray 'confident' in FDA approval for Vertex's TripleRx
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $230 price target on Vertex Pharmaceuticals, after the FDA accepted the New Drug Application, or NDA, for Vertex's TripleRx VX-445 + SYMDEKO, setting a March 19 PDUFA date. Tenthoff said he is "confident in approval" based on "unprecedented efficacy in Phase III trials."
08/28/19
ARGS
08/28/19
NO CHANGE
Target $200
ARGS
Buy
Vertex offers attractive entry point, says Argus
Argus analyst Jasper Hellweg keeps his Buy rating and $200 price target on Vertex but notes that its recent stock price retreat has taken valuation below historical averages and offers a "favorable entry point". The analyst is positive on the company's current product line-up and deep pipeline focused on cystic fibrosis drugs, with an eye on the March 2020 FDA action date for its next-generation triple-combination CF therapy regimen.
08/28/19
PIPR
08/28/19
NO CHANGE
PIPR
Symdeko deaths in FDA database likely due to disease, says Piper Jaffray
08/28/19
PIPR
08/28/19
NO CHANGE
Target $230
PIPR
Overweight
Vertex drug not cited as cause of 30 deaths in FDA database, says Piper Jaffray
The FDA Adverse Events Reporting System Public Dashboard citing 30 deaths with Symdeko caused volatility today in shares of Vertex Pharmaceuticals, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. After accessing the website, the analyst says none of the 30 deaths specifically indicate Symdeko, "but rather appear to be due to underlying cystic fibrosis disease." As such, the FAERS report does not signify a unique problem with Symdeko or Vertex's TripleRx combination, which is under review at the FDA, contends Tenthoff. The "timing of this short rumor to be suspicious during a quiet, end of summer week," he adds. The analyst continues to forecast Vertex's total cystic fibrosis sales at $3.7B this year, growing to $5B in 2020 with the TripleRx launch. He reiterates an Overweight rating on the stock with a $230 price target. Vertex in late morning trading is up 1%, or $1.84, to $180.09.

TODAY'S FREE FLY STORIES

SAM

Boston Beer

$345.20

-6.42 (-1.83%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Hot Stocks
Boston Beer, National Hockey League announce multiyear U.S. partnership »

The Boston Beer Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

LYFT

Lyft

$46.45

-0.84 (-1.78%)

, UBER

Uber

$32.52

-1.31 (-3.87%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Recommendations
Lyft, Uber analyst commentary  »

Lyft should be bought on…

LYFT

Lyft

$46.45

-0.84 (-1.78%)

UBER

Uber

$32.52

-1.31 (-3.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SDXAY

Sodexo

$0.00

(0.00%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Hot Stocks
Sodexo confirms 34% carbon emissions reduction target by 2025 »

Sodexo confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Conference/Events
UBS to hold a conference »

Future of Retail…

AJG

Arthur J. Gallagher

$88.78

-0.64 (-0.72%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Hot Stocks
Arthur J. Gallagher acquires The Human Capital Group, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$172.68

-4.23 (-2.39%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

, CHWY

Chewy

$26.44

-1.06 (-3.85%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Plus Therapeutics…

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

CHWY

Chewy

$26.44

-1.06 (-3.85%)

ALV

Autoliv

$78.20

-1.06 (-1.34%)

PSTV

Plus Therapeutics

$7.96

-0.34 (-4.10%)

TELL

Tellurian

$8.69

0.105 (1.22%)

RKDA

Arcadia Biosciences

$5.29

-0.23 (-4.17%)

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

AKS

AK Steel

$2.41

-0.05 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 31

    Oct

ABMD

Abiomed

$193.14

0.48 (0.25%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Federal Court of Justice in Germany rules in favor of Abiomed's Impella patents »

The highest court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MU

Micron

$49.17

-0.65 (-1.30%)

08:58
09/23/19
09/23
08:58
09/23/19
08:58
Recommendations
Micron analyst commentary  »

Deutsche comfortable with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

, NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Recommendations
Cirrus Logic, NXP Semiconductors, Texas Instruments analyst commentary  »

Teardown confirms Cirrus…

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NFLX

Netflix

$270.66

-15.92 (-5.56%)

, ROKU

Roku

$107.98

-25.735 (-19.25%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Options
Notable open interest changes for September 23rd »

Friday's total…

NFLX

Netflix

$270.66

-15.92 (-5.56%)

ROKU

Roku

$107.98

-25.735 (-19.25%)

BAC

Bank of America

$29.57

-0.23 (-0.77%)

AAPL

Apple

$217.69

-3.22 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 16

    Oct

  • 16

    Oct

SABR

Sabre

$23.11

0.12 (0.52%)

08:54
09/23/19
09/23
08:54
09/23/19
08:54
Hot Stocks
Sabre signs long-term agreement with Magnum Travel Services »

Sabre announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$156.29

-0.66 (-0.42%)

08:53
09/23/19
09/23
08:53
09/23/19
08:53
Recommendations
Dollar General analyst commentary  »

Dollar General price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 30

    Sep

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

08:51
09/23/19
09/23
08:51
09/23/19
08:51
Downgrade
Cleveland-Cliffs rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

INPX

Inpixon

$0.13

0.0013 (0.98%)

08:50
09/23/19
09/23
08:50
09/23/19
08:50
Hot Stocks
Inpixon's Jibestream signs teaming agreement with IDENTOS »

Jibestream announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
09/23/19
09/23
08:50
09/23/19
08:50
General news
NY Fed's repo results: Fed's repo totaled $65.75 B »

NY Fed's repo…

CGNX

Cognex

$48.20

-2.28 (-4.52%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Recommendations
Cognex analyst commentary  »

Cognex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$21.70

-0.26 (-1.18%)

, X

U.S. Steel

$10.81

-0.25 (-2.26%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Downgrade
Alcoa, U.S. Steel, Commercial Metals, Nucor, Steel Dynamics, Stelco Holdings rating change  »

JPMorgan double…

AA

Alcoa

$21.70

-0.26 (-1.18%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

NUE

Nucor

$52.62

-0.08 (-0.15%)

STLD

Steel Dynamics

$30.38

-0.32 (-1.04%)

STZHF

Stelco Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

ABEO

Abeona Therapeutics

$3.26

-0.005 (-0.15%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Hot Stocks
Abeona recieves clinical hold letter from FDA over Phase 3 trial for EB-101 »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FNB

F.N.B.

$11.38

-0.045 (-0.39%)

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
F.N.B. announces $150M stock repurchase program »

F.N.B. announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
Resverlogix to present BETonMACE trial results at AHA Scientific Sessions »

Resverlogix announced the…

PRSP

Perspecta

$26.29

-0.005 (-0.02%)

08:46
09/23/19
09/23
08:46
09/23/19
08:46
Hot Stocks
Perspecta awarded $657M extension of NGEN contract with U.S. Dept. of Navy »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Hot Stocks
Apple partners with Oprah Winfrey to bring Oprah's Book Club to Apple »

Apple and Oprah Winfrey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$155.23

0.19 (0.12%)

, HEXO

HEXO Corp

$4.37

0.425 (10.79%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BYND

Beyond Meat

$155.23

0.19 (0.12%)

HEXO

HEXO Corp

$4.37

0.425 (10.79%)

FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

ABBV

AbbVie

$72.46

0.78 (1.09%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

COTY

Coty

$10.17

-0.1 (-0.97%)

ADI

Analog Devices

$115.30

-0.72 (-0.62%)

NOK

Nokia

$5.30

0.145 (2.81%)

IMMU

Immunomedics

$16.60

-0.44 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Nov

08:45
09/23/19
09/23
08:45
09/23/19
08:45
General news
U.S. Chicago National Activity index rose 0.51 points to 0.10 in August »

U.S. Chicago National…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.